Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
All Multimedia
Subscribe!
Subscribe Today!
Jeff Inglis
This person does not yet have a bio.
Articles by Jeff Inglis
| 3 min read
by
Jeff Inglis
Pharmacyclics: First drug gets rolling
Company follows 2013 Imbruvica approval with accelerated approval for another indication
Articles
| 3 min read
by
Jeff Inglis
Smash and grab
Scripps researchers develop two novel ways to discover new drugs
Articles
| 2 min read
by
Jeff Inglis
Merck HIV therapies make big news at CROI
Company gives a peek at a new drug and shares a study for an old favorite
Articles
| 3 min read
by
Jeff Inglis
Making clinical trials more diverse
Various players in the healthcare industry unite to launch ‘I’m In’ campaign
Articles
| 2 min read
by
Jeff Inglis
Five Prime steps up search for monoclonal antibodies
Agreement with Adimab will help discover monoclonal antibodies for cancer immunotherapy
Articles
| 2 min read
by
Jeff Inglis
GSK, Roche go head-to-head to fight melanoma
Small market gets big competition, according to analysis by Datamonitor
Articles
| 3 min read
by
Jeff Inglis
Growing proteins in space
Emerald Bio targets cholesterol, cancer in microgravity
Articles
| 2 min read
by
Jeff Inglis
Bringing FDA-approved NGS tests to the masses
Illumina and Amgen partner up to develop companion diagnostic to identify prospective patients for Vectibix
Articles
| 3 min read
by
Jeff Inglis
Absorbing more ‘bad’ cholesterol
A new anti-LDL drug passes another test
Articles
| 3 min read
by
Jeff Inglis
Jazz Pharmaceuticals is jamming
Acquisitions and sales expansion project big revenue growth for 2014
Articles
| 3 min read
by
Jeff Inglis
Downsizing has major benefits
New University of Queensland technique can shrink and stabilize proteins
Articles
| 3 min read
by
Jeff Inglis
Saving lives with testing
New test can help detect suicide danger in patients on antidepressants
Articles
Page 1 of 1 - 12 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Driving gene therapy with nonviral vectors
Learn why nonviral vectors are on the rise in gene therapy development.
Posters
Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis
Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Milestones
Advancing immuno-oncology research with cellular assays
Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Webinars
Latest Issue
Volume 20 • Issue 6 • November 2024
November 2024
November 2024 Issue
Explore this issue